المؤلفون: Grivas, P, Khaki, AR, Wise-Draper, TM, French, B, Hennessy, C, Hsu, C-Y, Shyr, Y, Li, X, Choueiri, TK, Painter, CA, Peters, S, Rini, BI, Thompson, MA, Mishra, S, Rivera, DR, Acoba, JD, Abidi, MZ, Bakouny, Z, Bashir, B, Bekaii-Saab, T, Berg, S, Bernicker, EH, Bilen, MA, Bindal, P, Bishnoi, R, Bouganim, N, Bowles, DW, Cabal, A, Caimi, PF, Chism, DD, Crowell, J, Curran, C, Desai, A, Dixon, B, Doroshow, DB, Durbin, EB, Elkrief, A, Farmakiotis, D, Fazio, A, Fecher, LA, Flora, DB, Friese, CR, Fu, J, Gadgeel, SM, Galsky, MD, Gill, DM, Glover, MJ, Goyal, S, Grover, P, Gulati, S, Gupta, S, Halabi, S, Halfdanarson, TR, Halmos, B, Hausrath, DJ, Hawley, JE, Hsu, E, Huynh-Le, M, Hwang, C, Jani, C, Jayaraj, A, Johnson, DB, Kasi, A, Khan, H, Koshkin, VS, Kuderer, NM, Kwon, DH, Lammers, PE, Li, A, Loaiza-Bonilla, A, Low, CA, Lustberg, MB, Lyman, GH, McKay, RR, McNair, C, Menon, H, Mesa, RA, Mico, V, Mundt, D, Nagaraj, G, Nakasone, ES, Nakayama, J, Nizam, A, Nock, NL, Park, C, Patel, JM, Patel, KG, Peddi, P, Pennell, NA, Piper-Vallillo, AJ, Puc, M, Ravindranathan, D, Reeves, ME, Reuben, DY, Rosenstein, L, Rosovsky, RP, Rubinstein, SM, Salazar, M, Schmidt, AL, Schwartz, GK

المصدر: Annals of Oncology. 32(6)

مصطلحات موضوعية: Infectious Diseases, Patient Safety, Cancer, Hematology, Lung, Clinical Research, Prevention, Good Health and Well Being, Aged, COVID-19, COVID-19 Testing, Female, Humans, Male, Neoplasms, Pandemics, SARS-CoV-2, SARS-CoV2, neoplasm, cancer, anticancer therapy, laboratory measurements, outcomes, Oncology and Carcinogenesis, Oncology & Carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/49m429m0

المؤلفون: Chang AEB; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, United States., Piper-Vallillo AJ; Department of Medicine, Division of Hematology/Oncology, Lahey Hospital and Medical Center, Burlington, MA 01805, United States., Mak RH; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02215, United States., Lanuti M; Department of Surgery, Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA 02114, United States., Muzikansky A; Massachusetts General Hospital Biostatistics Center, Boston, MA 02114, United States., Rotow J; Lowe Center for Thoracic Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, United States., Jänne PA; Lowe Center for Thoracic Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, United States., Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States., Swanson S; Department of Surgery, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115, United States., Wright CD; Department of Surgery, Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA 02114, United States., Kozono D; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02215, United States., Marcoux P; Lowe Center for Thoracic Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, United States., Piotrowska Z; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, United States., Sequist LV; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, United States., Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, United States.

المصدر: The oncologist [Oncologist] 2024 Jul 05; Vol. 29 (7), pp. 609-618.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/therapy , Afatinib*/therapeutic use , Afatinib*/pharmacology , Lung Neoplasms*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/therapy , Lung Neoplasms*/radiotherapy , ErbB Receptors*/genetics , Chemoradiotherapy*/methods, Humans ; Female ; Male ; Middle Aged ; Aged ; Mutation ; Adult ; Neoplasm Staging ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology

المؤلفون: Piper Vallillo AJ; Division of Hematology and Oncology, Lahey Hospital and Medical Center & Tufts University School of Medicine; Boston, MA., Viray H; Division of Medical Oncology, Beth Israel Deaconess Medical Center & Harvard Medical School; Boston, MA., Feldman J; Co-Founder, EGFR Resisters; Deerfield, MA., Rangachari D; Division of Medical Oncology, Beth Israel Deaconess Medical Center & Harvard Medical School; Boston, MA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1215-1221. Date of Electronic Publication: 2024 Feb 27.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics, Humans ; Quality of Life ; ErbB Receptors/genetics ; Medical Oncology

المؤلفون: Viray H; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Piper-Vallillo AJ; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.; Division of Hematology/Oncology, Department of Medicine, Lahey Hospital & Medical Center, Burlington, MA 01805, USA., Widick P; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Academia E; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Shea M; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Rangachari D; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., VanderLaan PA; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Kobayashi SS; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Costa DB; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

المصدر: Cancers [Cancers (Basel)] 2024 Mar 07; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Sentana-Lledo D; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Viray H; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Piper-Vallillo AJ; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Department of Medicine, Division of Hematology/Oncology, Lahey Hospital & Medical Center, Burlington, MA, United States., Widick P; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Rangachari D; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Wilson JL; Department of Surgery, Division of Thoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Gangadharan SP; Department of Surgery, Division of Thoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Aronovitz JA; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Berman SM; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., VanderLaan PA; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Costa DB; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address: dbcosta@bidmc.harvard.edu.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Oct; Vol. 172, pp. 124-126. Date of Electronic Publication: 2022 Aug 24.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Carbazoles ; Clinical Trials as Topic ; Humans ; Neoadjuvant Therapy ; Piperidines ; Protein Kinase Inhibitors/therapeutic use ; Receptor Protein-Tyrosine Kinases/therapeutic use

المؤلفون: White MN; Department of Medicine, Division of Oncology, Stanford University, Stanford CA., Piper-Vallillo AJ; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Gardner RM; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA., Cunanan K; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA., Neal JW; Department of Medicine, Division of Oncology, Stanford University, Stanford CA., Das M; Department of Medicine, Division of Oncology, Stanford University, Stanford CA; Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA., Padda SK; Department of Medicine, Division of Oncology, Stanford University, Stanford CA., Ramchandran K; Department of Medicine, Division of Oncology, Stanford University, Stanford CA., Chen TT; Stanford Cancer Center South Bay, San Jose, CA., Sequist LV; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Piotrowska Z; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Wakelee HA; Department of Medicine, Division of Oncology, Stanford University, Stanford CA. Electronic address: hwakelee@stanford.edu.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2022 May; Vol. 23 (3), pp. e210-e221. Date of Electronic Publication: 2021 Nov 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Acrylamides ; Aniline Compounds ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bevacizumab/therapeutic use ; ErbB Receptors/genetics ; Humans ; Immunotherapy ; Mutation ; Platinum/therapeutic use ; Retrospective Studies

المؤلفون: Piper-Vallillo AJ; Massachusetts General Hospital, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Rotow JK; Harvard Medical School, Boston, Massachusetts.; Dana Farber Cancer Institute, Boston, Massachusetts., Aredo JV; Stanford University School of Medicine, Stanford, California., Shaverdashvili K; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Luo J; Harvard Medical School, Boston, Massachusetts.; Dana Farber Cancer Institute, Boston, Massachusetts.; Memorial Sloan Kettering Cancer Center, New York, New York., Carlisle JW; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Husain H; University of California San Diego Medical Center, La Jolla, California., Muzikansky A; Massachusetts General Hospital, Boston, Massachusetts., Heist RS; Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rangachari D; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Ramalingam SS; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Wakelee HA; Stanford University School of Medicine, Stanford, California., Yu HA; Memorial Sloan Kettering Cancer Center, New York, New York., Sequist LV; Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Bauml JM; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Neal JW; Stanford University School of Medicine, Stanford, California., Piotrowska Z; Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

المصدر: JTO clinical and research reports [JTO Clin Res Rep] 2022 Apr 21; Vol. 3 (6), pp. 100328. Date of Electronic Publication: 2022 Apr 21 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

المؤلفون: Klein IA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rosenberg SM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Reynolds KL; Massachusetts General Hospital, Boston, Massachusetts, USA., Zubiri L; Massachusetts General Hospital, Boston, Massachusetts, USA., Rosovsky R; Massachusetts General Hospital, Boston, Massachusetts, USA., Piper-Vallillo AJ; Massachusetts General Hospital, Boston, Massachusetts, USA., Gao X; Massachusetts General Hospital, Boston, Massachusetts, USA., Boland G; Massachusetts General Hospital, Boston, Massachusetts, USA., Bardia A; Massachusetts General Hospital, Boston, Massachusetts, USA., Gaither R; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Freeman H; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kirkner GJ; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rhee C; Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Klompas M; Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Baker MA; Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Wadleigh M; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Winer EP; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kotton CN; Massachusetts General Hospital, Boston, Massachusetts, USA., Partridge AH; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

المصدر: The oncologist [Oncologist] 2021 Aug; Vol. 26 (8), pp. 685-693. Date of Electronic Publication: 2021 May 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Neoplasms*/complications , Neoplasms*/epidemiology, Adult ; Aged ; Aged, 80 and over ; Female ; Hospitalization ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Risk Factors ; SARS-CoV-2

المؤلفون: Zubiri L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rosovsky RP; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mooradian MJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Piper-Vallillo AJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gainor JF; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sullivan RJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Marte D; Rutgers New Jersey Medical School, Newark, New Jersey, USA., Boland GM; Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gao X; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hochberg EP; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ryan DP; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., McEwen C; Department of Pharmacy, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mai M; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sharova T; Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Soumerai TE; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bardia A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Reynolds KL; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

المصدر: The oncologist [Oncologist] 2021 Aug; Vol. 26 (8), pp. e1427-e1433. Date of Electronic Publication: 2021 May 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Cross Infection*/epidemiology , Neoplasms*/complications , Neoplasms*/epidemiology, Censuses ; Humans ; Inpatients ; Pandemics ; SARS-CoV-2

المؤلفون: Piper-Vallillo AJ; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Kobayashi SS; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan., Costa DB; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

المصدر: JTO clinical and research reports [JTO Clin Res Rep] 2021 Mar 16; Vol. 2 (3), pp. 100133. Date of Electronic Publication: 2021 Mar 16 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE